Samsara Inc vs Stryker Corporation — how do they compare? Samsara Inc trades at $36.09 (market cap $22.46B), while Stryker Corporation trades at $319.04 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 5.4× Samsara Inc's market cap, and Stryker Corporation pays a 1% dividend while Samsara Inc pays none. Which is the better fit depends on your goals.
| IOT | SYK | |
|---|---|---|
Market Cap | $22.46B | $122.35B |
Sector | Technology | Technology |
52-Week High | $45.22 | $403.53 |
52-Week Low | $24.25 | $282.58 |
Enterprise Value | $21.73B | $134.10B |
Dividend Yield | — | 1% |
Signals from Pluang's Aura AI — not financial advice
Samsara (IOT) trades at $38.55, up 0.6% with strong technical momentum and bullish moving average signals. The company shows robust revenue growth from $1.25B in 2025 to $1.7B projected for 2026, with net income turning positive at $58M. Recent earnings beats and strong analyst consensus (77.8% buy ratings) support the positive outlook, though elevated valuation metrics and overbought RSI levels warrant caution.
Investment outlook remains favorable with 15% upside to consensus price target of $44.40, driven by operational AI expansion and large customer growth. Key risks include high P/E ratio of 385.5, margin pressure from cloud investments, and competitive threats in the connected operations space. The stock's technical strength and fundamental improvement suggest continued momentum if execution remains strong.
Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.
Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.
Trailing returns across standard periods
Latest headlines on both assets
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →